Rovi Pharma Industrial Services S.A.June 2, 2023

FDA 483 - Rovi Pharma Industrial Services S.A. - June 02, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Rovi Pharma Industrial Services S.A.

Record Details

An FDA inspection of Rovi Pharma Industrial Services S.A. in Alcala de Henares, Spain, revealed deficiencies in equipment cleaning, facility segregation, and reserve sample examination. The firm failed to adequately clean equipment between batches and ensure proper separation of manufacturing operations. Additionally, procedures for visually examining reserve samples for deterioration were found to be insufficient.

Company: Rovi Pharma Industrial Services S.A.
Inspection Date: June 2, 2023
Product Type: Drugs
Office: Office of Biological Products Operations - Division I
Person: Saied A. Asbagh (Investigator)

Open in Dashboard

ID · 37319618-4734-4669-b75a-c512d866a3eb